Ignite Creation Date:
2024-05-06 @ 2:03 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04200963
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2019-12-11
Brief Title:
A Phase 1ab Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
Sponsor:
Ikena Oncology
Organization:
Ikena Oncology
Organization Data
Organization:
Ikena Oncology
Class:
INDUSTRY
Study ID:
IK175-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ikena Oncology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |